NCT02338947

Brief Summary

Frailty is defined as a geriatric syndrome of impaired resiliency to stressors (such as cardiac surgery) that has been delineated recently in the cardiovascular literature. One of the most controversial areas of cardiac surgery has been whether off-pump coronary artery bypass grafting (OPCAB) surgery is superior to conventional on-pump coronary artery bypass grafting (CABG) surgery. There is an ongoing debate about the benefits and disadvantages of OPCAB surgery and we believe that this remains an important technique for the improvement of coronary surgery. The benefits of CABG surgery in frail patients are still undetermined. The aim of this study is to clarify the potential benefit of OPCAB surgery in pre-frail and frail patients by comparing off-pump versus on-pump CABG in these patients.

Trial Health

58
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
440

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
2 countries

7 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2014

Completed
5 months until next milestone

First Posted

Study publicly available on registry

January 15, 2015

Completed
4 years until next milestone

Study Start

First participant enrolled

January 1, 2019

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 5, 2025

Status Verified

January 1, 2025

Enrollment Period

6 years

First QC Date

August 29, 2014

Last Update Submit

February 27, 2025

Conditions

Keywords

Frail elderlyCoronary artery bypass surgeryOff-pumpOn-pumpRandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Major adverse cardiac and cerebrovascular events after OPCAB and CABG in pre-frail and frail patients

    This composite outcome comprises: all cause death, acute myocardial infarction, stroke, renal failure, acute respiratory distress syndrome and bleeding reoperation

    From the date of surgery until 30 days postoperatively, assessed up to 30 days

Secondary Outcomes (13)

  • Operative time

    From the start of anesthesia induction to the end of the surgical procedure

  • Mechanical ventilation time

    From the initiation of mechanical ventilation in the operating room or ICU to the time of successful extubation

  • Hyperdynamic shock

    From the date of surgery until 30 days postoperatively, assessed up to 30 days

  • New onset of atrial fibrillation

    From the date of surgery until 30 days postoperatively, assessed up to 30 days

  • Need for pacing >24 hours

    From the date of surgery until 30 days postoperatively, assessed up to 30 days

  • +8 more secondary outcomes

Other Outcomes (7)

  • Delirium

    From the date of surgery until 30 days postoperatively, assessed up to 30 days

  • Neurobehavioral outcomes after cardiac surgery

    From the date of hospital discharge until 6 months postoperatively and from the date of hospital discharge until 12 months postoperatively, assessed up to 1 year

  • Quality of life after cardiac surgery

    From the date of hospital discharge until 6 months postoperatively and from the date of hospital discharge until 12 months postoperatively, assessed up to 1 year

  • +4 more other outcomes

Study Arms (2)

Off-pump coronary-artery bypass grafting - OPCAB

ACTIVE COMPARATOR

Pre-frail and frail patients will be randomly assigned to OPCAB after the evaluation of the target vessels by an internet-based, password protected database program. The surgery will be performed as described in the "intervention" section and the patients will be followed up for two years.

Other: Off-pump coronary-artery bypass grafting

On-pump coronary-artery bypass grafting - CABG

ACTIVE COMPARATOR

Pre-frail and frail patients will be randomly assigned to CABG after the evaluation of the target vessels by an internet-based, password protected database program. The surgery will be performed as described in the "intervention" section and the patients will be followed up for two years.

Other: On-pump coronary-artery bypass grafting

Interventions

Surgical access to the heart will be gained through a median sternotomy in all of the patients. In order to reduce the risk of bleeding and transfusions, an absorbable hemostat will be used in the sternal bone marrow. An automatic autotransfusion system will be used to recovery of red blood cells in all patients. Off-pump surgery will be performed with the use of heart stabilizers. Patients will be heparinized with 250 IU/kg intravenously to achieve activated clotting time \>200s. The proximal anastomosis will be performed according to our guidelines. The distal anastomosis will be constructed with the help of mechanical stabilizers and cardiac positioner. Intracoronary shunts will be used routinely.

Also known as: OPCAB
Off-pump coronary-artery bypass grafting - OPCAB

Surgical access to the heart will be gained through a median sternotomy in all of the patients. On-pump surgery will be performed in normothermia, with the use of aortic cross-clamping and cold cardioplegic arrest. Patients will be heparinized with 500 IU/kg to achieve an activated clotting time \>480 s. Heparin will be neutralized with 1:1 protamine sulfate. The automatic autotransfusion system will be used just in massive blood loss to recovery the red blood cells. Surgical techniques will be performed according to our guidelines.

Also known as: CABG
On-pump coronary-artery bypass grafting - CABG

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Participants aged ≥60 years with the indication of myocardial revascularization with ≥2 criteria of frailty by Fried Frailty Criteria, and suitable to undergo either Off-pump or On-pump CABG.

You may not qualify if:

  • \- Patients with the indication of angioplasty or another procedure in addition to CABG; patients who underwent an emergency operation (within 24 hours after hospital admission); patients who underwent previous cardiac surgery, even with other approaches than median sternotomy; patients who do not have free, prior and informed consent to participate in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Emory University School of Medicine

Atlanta, Georgia, 30322, United States

Location

Hospital de Messejana

Fortaleza, Ceará, Brazil

Location

Hospital das Clínicas Samuel Libânio

Pouso Alegre, Minas Gerais, 37550-000, Brazil

Location

Hospital Alberto Urquiza Wanderley

João Pessoa, Paraíba, 58040-300, Brazil

Location

Instituto Nacional de Cardiologia de Laranjeiras

Rio de Janeiro, Rio de Janeiro, 22240-002, Brazil

Location

Beneficência Portuguesa de São Paulo

São Paulo, São Paulo, 01323-001, Brazil

Location

Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São Paulo

São Paulo, São Paulo, 05403-900, Brazil

Location

Related Publications (1)

  • Mejia OAV, Sa MPBO, Deininger MO, Dallan LRP, Segalote RC, Oliveira MAP, Atik FA, Santos MAD, Silva PGMBE, Milani RM, Hueb AC, Monteiro R, Lima RC, Lisboa LAF, Dallan LAO, Puskas J, Jatene FB. Off-pump versus On-pump Coronary Artery Bypass Grafting in Frail Patients: Study Protocol for the FRAGILE Multicenter Randomized Controlled Trial. Braz J Cardiovasc Surg. 2017 Sep-Oct;32(5):428-434. doi: 10.21470/1678-9741-2017-0196.

Related Links

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Omar AV Mejia, MD, PhD

    InCor Heart Institute

    STUDY DIRECTOR
  • Fábio B Jatene, MD, PhD

    InCor Heart Institute

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Treatment assignments will be performed in a blinded manner according to a blocked randomization scheme with a block size of ten, stratified according to the participating center.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Eligible patients will be randomly assigned to off-pump CABG or on-pump CABG procedure.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2014

First Posted

January 15, 2015

Study Start

January 1, 2019

Primary Completion

December 31, 2024

Study Completion

December 31, 2025

Last Updated

March 5, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations